Literature DB >> 10618084

Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigen.

S Li1, G Maine, Y Suzuki, F G Araujo, G Galvan, J S Remington, S Parmley.   

Abstract

A portion of a cDNA encoding a 35-kDa antigen from Toxoplasma gondii was cloned into the CKS expression vector and expressed in Escherichia coli. By using the enzyme-linked immunosorbent assay (ELISA), the recombinant protein (rP35 antigen) was examined for reactivity with immunoglobulin G (IgG) antibodies in the sera of pregnant women. Of these women, 41 had a toxoplasma serologic profile suggestive of recently acquired T. gondii infection (Sabin-Feldman dye test [DT] titers from 1:256 to 1:32,000, positive IgM ELISA titers from 2.3 to 9.7, positive IgA ELISA from 1 to >28, and acute patterns in the differential agglutination [AC/HS] test) (group I), and 50 women had a toxoplasma serologic profile suggestive of infection acquired in the distant past (low DT titers from 1:16 to 1:512, negative IgM ELISA titers from 0 to 0.8, and chronic patterns in the AC/HS test) (group II). The classification of acute or chronic profile was based on the individual's clinical history as well as the combination of the results of the toxoplasma serological profile. An additional group (group III) was composed of sera from 50 women who were seronegative for T. gondii antibodies in the DT. The results revealed that whereas 85.3% of women in group I had IgG antibodies that reacted with the rP35 antigen, only 8% of women in group II had IgG antibodies that reacted with the same antigen. In immunoblots, the rP35 antigen was recognized by IgG antibodies in a pool of sera from individuals with a toxoplasma serologic profile compatible with acute infection but not in a pool of sera from individuals with a serologic profile characteristic of a chronic infection. These results reveal that IgG antibodies against the P35 antigen are produced during the acute stage of the infection but are uncommon in the latent or chronic phase of the infection. Thus, the rP35 antigen may be a useful serologic marker to differentiate between recently acquired infection and that acquired in the more distant past.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618084      PMCID: PMC88692          DOI: 10.1128/JCM.38.1.179-184.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Expression, characterization, and serologic reactivity of recombinant surface antigen P22 of Toxoplasma gondii.

Authors:  S F Parmley; G D Sgarlato; J Mark; J B Prince; J S Remington
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Human antibody response to the nucleoside triphosphate hydrolase of Toxoplasma gondii.

Authors:  A M Tenter; A M Johnson
Journal:  J Immunoassay       Date:  1990

3.  Recognition of recombinant Toxoplasma gondii antigens by human sera in an ELISA.

Authors:  A M Tenter; A M Johnson
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

4.  An Escherichia coli expression vector for high-level production of heterologous proteins in fusion with CMP-KDO synthetase.

Authors:  T J Bolling; W Mandecki
Journal:  Biotechniques       Date:  1990-05       Impact factor: 1.993

5.  Detection of human Toxoplasma-specific immunoglobulins A, M, and G with a recombinant Toxoplasma gondii rop2 protein.

Authors:  V Martin; M Arcavi; G Santillan; M R Amendoeira; E De Souza Neves; G Griemberg; E Guarnera; J C Garberi; S O Angel
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

6.  Analysis of Toxoplasma gondii antigens recognized by human sera obtained before and after acute infection.

Authors:  I Potasman; F G Araujo; G Desmonts; J S Remington
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

7.  Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG.

Authors:  M Lappalainen; P Koskela; M Koskiniemi; P Ammälä; V Hiilesmaa; K Teramo; K O Raivio; J S Remington; K Hedman
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

8.  Recent primary toxoplasma infection indicated by a low avidity of specific IgG.

Authors:  K Hedman; M Lappalainen; I Seppäiä; O Mäkelä
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

9.  Toxoplasma gondii antigens recognized by sequential samples of serum obtained from congenitally infected infants.

Authors:  I Potasman; F G Araujo; P Thulliez; G Desmonts; J S Remington
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

10.  Evaluation of a recombinant antigen ELISA for the diagnosis of acute toxoplasmosis and comparison with traditional antigen ELISAs.

Authors:  A M Johnson; H Roberts; A M Tenter
Journal:  J Med Microbiol       Date:  1992-12       Impact factor: 2.472

View more
  25 in total

1.  CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells.

Authors:  Lori Casciotti; Kenneth H Ely; Martha E Williams; Imtiaz A Khan
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey.

Authors:  Li Liang; Mert Döşkaya; Silvia Juarez; Ayşe Caner; Algis Jasinskas; Xiaolin Tan; Bettina E Hajagos; Peter J Bradley; Metin Korkmaz; Yüksel Gürüz; Philip L Felgner; D Huw Davies
Journal:  Mol Cell Proteomics       Date:  2011-04-21       Impact factor: 5.911

Review 3.  Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections.

Authors:  Kelly J Pittman; Laura J Knoll
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

4.  Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis.

Authors:  H Pietkiewicz; E Hiszczyńska-Sawicka; J Kur; E Petersen; H V Nielsen; M Paul; M Stankiewicz; P Myjak
Journal:  Parasitol Res       Date:  2006-08-08       Impact factor: 2.289

5.  Seroreactivity to and avidity for recombinant antigens in toxoplasmosis.

Authors:  Klaus-Ingmar Pfrepper; Gisela Enders; Marion Gohl; Doris Krczal; Harald Hlobil; Doris Wassenberg; Erwin Soutschek
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

6.  A new MIC1-MAG1 recombinant chimeric antigen can be used instead of the Toxoplasma gondii lysate antigen in serodiagnosis of human toxoplasmosis.

Authors:  Lucyna Holec-Gąsior; Bartłomiej Ferra; Dorota Drapała; Dariusz Lautenbach; Józef Kur
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

7.  Evaluation of Toxoplasma gondii-recombinant dense granular protein (GRA2) for serodiagnosis by western blot.

Authors:  Xiao Teng Ching; Yee Ling Lau; Mun Yik Fong; Veeranoot Nissapatorn
Journal:  Parasitol Res       Date:  2012-12-29       Impact factor: 2.289

8.  Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens.

Authors:  S Li; G Galvan; F G Araujo; Y Suzuki; J S Remington; S Parmley
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

9.  Limited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women.

Authors:  Josette Ferrandiz; Corinne Mercier; Martine Wallon; Stéphane Picot; Marie-France Cesbron-Delauw; François Peyron
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

10.  Development of an immunochromatographic assay based on dense granule protein 7 for serological detection of Toxoplasma gondii infection.

Authors:  Mohamad Alaa Terkawi; Kyohko Kameyama; Nazim Hamza Rasul; Xuean Xuan; Yoshifumi Nishikawa
Journal:  Clin Vaccine Immunol       Date:  2013-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.